Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
Morishita A, Tadokoro T, Fujihara S, Iwama H, Oura K, Fujita K, Tani J, Takuma K, Nakahara M, Shi T, Haba R, Okano K, Nishiyama A, Ono M, Himoto T, Masaki T.
Morishita A, et al. Among authors: okano k.
PLoS One. 2022 Feb 22;17(2):e0261310. doi: 10.1371/journal.pone.0261310. eCollection 2022.
PLoS One. 2022.
PMID: 35192632
Free PMC article.